API
< Back to all clusters
[BUSINESS] · Brazil · 2 sources

started · updated

Oncoclínicas advances debt restructuring and faces board dispute

Oncoclínicas has reported significant progress in its extrajudicial recovery plan, securing support from creditors representing 74.6% of the total credit base. This includes over R$ 4.3 billion in claims out of a total considered base of approximately R$ 5.8 billion, excluding intercompany debts.

The updated restructuring proposal includes various payment and reorganization methods, such as exchanging debt for new financial instruments, extending payment terms, delivering specific assets, issuing convertible debentures, and partial debt settlement through company shares. The plan also offers discounts and specific conditions for commercial suppliers.

Simultaneously, the company is embroiled in a legal dispute regarding its board of directors. The Josephina III fund, managed by Centaurus, successfully obtained a judicial injunction to cancel a general meeting scheduled to elect new board members. This conflict follows the resignation of board member Paulo Belém, which triggered the dismissal of the previous board under capital market rules. The dispute involves competing interests between the Josephina III fund and shareholders including Latache and the Lume fund.

Entities

Centaurus · Josephina III · Latache · Lume · Oncoclínicas